Bb5a31f81ClaimAnthropic established partnerships with six organizations alongside launching proprietary drug discovery initiativesAgreeDisagree
Bb5a31f81ClaimMark Cuban Cost Plus Drug Company launched costplusdrugs.com on January 19, 2022, offering 111 generic medicationsAgreeDisagree
Bb5a31f81ClaimMark Cuban Cost Plus Drug Company developed modular drug manufacturing units housed within tractor-trailer-sized podsAgreeDisagree
Bb5a31f81ClaimMark Cuban Cost Plus Drug Company established teamcubancard.com as a discount card affiliated with approximately 17,000 pharmaciesAgreeDisagree
Bb5a31f81ClaimFlorida pain management clinics historically operated affiliated on-site pharmacies that exclusively dispensed OxyContin without real-time prescription tracking databasesAgreeDisagree
Bb5a31f81ClaimCost Plus Marketplace sells sterile injectables to clinics and hospitals at a transparent markup of 10% or 12% above costAgreeDisagree
Bb5a31f81ClaimAnthropic's S-1 regulatory filing formally designated Google and OpenAI as Anthropic's two primary market competitorsAgreeDisagree
Bb5a31f81ClaimGoogle secured deals to supply Tensor Processing Units to both OpenAI and OracleAgreeDisagree
Bb5a31f81ClaimWeil, Gotshal & Manges was founded in 1931 and established its business on corporate restructuring and bankruptciesAgreeDisagree
Bb5a31f81ClaimAnthropic acquired Mithril Medicine, a one-person biotechnology company developing therapies for two rare forms of muscular dystrophyAgreeDisagree
Bb5a31f81ClaimAs of October 2026, Mark Cuban Cost Plus Drug Company grew its catalog from 111 generic medications at launch to approximately 4,000 SKUsAgreeDisagree
Bb5a31f81ClaimAnthropic designated its mass physical book procurement and destructive digital scanning initiative as Project PanamaAgreeDisagree
Bb5a31f81ClaimWeil, Gotshal & Manges represented clients in the corporate bankruptcies of Lehman Brothers, General Motors, and EnronAgreeDisagree
Bb5a31f81ClaimMark Cuban Cost Plus Drug Company's Dallas manufacturing facility uses robotics and artificial intelligence within a 5,000-square-foot spaceAgreeDisagree
Bb5a31f81ClaimDealmaker Michael Aiello stepped down from Weil, Gotshal & Manges in September 2026 after 20 years at the law firmAgreeDisagree
Bb5a31f81ClaimMithril Medicine advanced an antibody treatment candidate for muscular dystrophy from initial concept to proof of principle in mice within 18 monthsAgreeDisagree
Bb5a31f81ClaimAnthropic entered into a partnership with Bristol Myers Squibb to apply artificial intelligence to early-stage clinical trial planningAgreeDisagree
Bb5a31f81ClaimAnthropic published an outline detailing its strategy to integrate artificial intelligence across every stage of the drug discovery processAgreeDisagree
Bb5a31f81ClaimThe Wall Street Journal reported that Anthropic's initial public offering could raise up to $100 billionAgreeDisagree
Bb5a31f81ClaimFiling an Abbreviated New Drug Application with the FDA costs approximately $365,000 plus additional administrative feesAgreeDisagree